Exercise for lipid changes during colorectal cancer chemotherapy
Part of Cancer, Digestive system clinical trials.
This trial tests whether a personalized exercise program can improve blood fat levels in people receiving chemotherapy for metastatic colorectal cancer. The goal is to see if physical activity can help manage a side effect of treatment and potentially improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have colorectal cancer that has spread (metastatic) and be scheduled to start chemotherapy, with or without other treatments.
- Your overall health must be good (able to do daily activities without help), and your blood albumin (a protein) level must be at least 30 g/L.
- You must be willing to use a smartphone app (AXOMOVE) and have internet access for the study.
- You must not currently exercise at a high level (moderate exercise 5 or more hours per week, or intense exercise 2.5 or more hours per week).
- You must not be pregnant, breastfeeding, or have certain heart, lung, or joint conditions that would make exercise unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a home-based exercise program can improve the health of your gut bacteria during chemotherapy for young-onset colorectal cancer. It aims to help you feel better and potentially improve how well your treatment works.
This trial studies whether a “prehab” program—structured exercise and preparation—can help people keep up function while they are on chemotherapy for colorectal cancer that has spread to the liver. If you can safely exercise, the program may help you tolerate treatment and stay active.
This trial studies whether supervised exercise—either aerobic fitness training or muscle-strength training—can improve outcomes for people with metastatic colorectal cancer. It compares which approach is most helpful and checks whether it’s safe during first-line chemotherapy.
This trial tests whether a combination of resistance and aerobic exercise can improve quality of life for people starting their first round of chemotherapy for metastatic colorectal cancer. If you are newly diagnosed and not already exercising regularly, this study may help you feel better during treatment.
This trial tests an aerobic exercise plan during chemotherapy for people with stage II or III colon cancer. It compares different exercise approaches to see if exercise can be done safely and may improve how you tolerate treatment and recovery.
This trial tests whether aerobic exercise can help your immune system fight cancer better during chemotherapy or immunotherapy. It is for people with breast or colon cancer that has not spread to other parts of the body.
Hear when a new Metastatic Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.